WHO's Hans Kluge: AstraZeneca vaccine produced by SII meets our quality criteria

The AstraZeneca vaccine that is being produced by the Serum Institute of India (SII), which arrived in Bosnia as a donation from Serbia on Tuesday, is included in WHO’s emergency use listing after it was determined that it meets “the criteria of quality, safety and efficacy,” World Health Organization (WHO) Regional Director for Europe, Hans Kluge, told N1 at a press conference on Thursday. Pročitaj više